Drug Shortage Report for GLN-GABAPENTIN
| Report ID | 242238 |
| Drug Identification Number | 02411008 |
| Brand name | GLN-GABAPENTIN |
| Common or Proper name | Gabapentin |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 800MG |
| Dosage form(s) | TABLET (IMMEDIATE RELEASE) |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 tablets |
| ATC code | N02BF |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-11-01 |
| Actual start date | 2024-11-02 |
| Estimated end date | 2025-02-17 |
| Actual end date | 2025-02-15 |
| Shortage status | Resolved |
| Updated date | 2025-02-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2025-02-18 | French | Compare |
| v15 | 2025-02-18 | English | Compare |
| v14 | 2025-02-11 | French | Compare |
| v13 | 2025-02-11 | English | Compare |
| v12 | 2025-01-08 | French | Compare |
| v11 | 2025-01-08 | English | Compare |
| v10 | 2025-01-08 | French | Compare |
| v9 | 2025-01-08 | English | Compare |
| v8 | 2024-12-16 | French | Compare |
| v7 | 2024-12-16 | English | Compare |
| v6 | 2024-12-02 | French | Compare |
| v5 | 2024-12-02 | English | Compare |
| v4 | 2024-11-18 | French | Compare |
| v3 | 2024-11-18 | English | Compare |
| v2 | 2024-11-07 | French | Compare |
| v1 | 2024-11-07 | English | Compare |
Showing 1 to 16 of 16